Rif Pamukcu's most recent trade in Aprea Therapeutics Inc was a trade of 4,185 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aprea Therapeutics Inc | Rifat Pamukcu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 4,185 | 4,185 | - | - | Stock Options (Right to Buy) | |
| Aprea Therapeutics Inc | Rifat Pamukcu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 1,045 | 5,446 (0%) | 0% | 0 | Common Stock | |
| Aprea Therapeutics Inc | Rifat Pamukcu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,185 | 4,185 | - | - | Stock Options (Right to Buy) | |
| Aprea Therapeutics Inc | Rifat Pamukcu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 1,045 | 4,401 (0%) | 0% | 0 | Common Stock | |
| Aprea Therapeutics Inc | Rif Pamukcu | Director | 23 Aug 2022 | 271,870 | 14,108 (0%) | 1% | 0 | Common Stock | ||
| Aprea Therapeutics Inc | Rif Pamukcu | Director | 23 Aug 2022 | 49,280 | 57,142 (0%) | 0% | 0 | Common Stock | ||
| Aprea Therapeutics Inc | Rif Pamukcu | Director | 23 Aug 2022 | 27,187 | 0 | - | - | Series A Non-Voting Convertible Preferred Stock | ||
| Aprea Therapeutics Inc | Rif Pamukcu | Director | 23 Aug 2022 | 4,928 | 0 | - | - | Series A Non-Voting Convertible Preferred Stock | ||
| Aprea Therapeutics Inc | Rif Pamukcu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2022 | 2,000 | 2,000 | - | - | Stock Options (Right to Buy) | |
| Aprea Therapeutics Inc | Rif Pamukcu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2022 | 500 | 3,356 (0%) | 0% | 0 | Common Stock | |
| Aprea Therapeutics Inc | Rif Pamukcu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 29,575 | 29,575 | - | - | Stock Option (right to Buy) | |
| Aprea Therapeutics Inc | Rif Pamukcu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 5,995 | 7,862 (0%) | 0% | 0 | Common Stock |